A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
Public ClinicalTrials.gov record NCT00095823. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Aripiprazole as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is a 14 week, randomized, double-blind, placebo controlled study, to assess the safety and efficacy of aripiprazole as adjunctive treatment to an ongoing antidepressant treatment in patients with Major Depressive Disorder.
Study identification
- NCT ID
- NCT00095823
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2004 (Type not available)
- Primary completion
- Aug 2006 (Actual)
- Completion
- Aug 2006 (Actual)
- Last update posted
- Oct 13, 2026
2004 – 2006
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Garden Grove | California | — | — |
| Local Institution | Northridge | California | — | — |
| Local Institution | Washington D.C. | District of Columbia | — | — |
| Local Institution | Jacksonville | Florida | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Edwardsville | Illinois | — | — |
| Local Institution | Rockville | Maryland | — | — |
| Local Institution | Springfield | Massachusetts | — | — |
| Local Institution | Farmington Hills | Michigan | — | — |
| Local Institution | Okemos | Michigan | — | — |
| Local Institution | Staten Island | New York | — | — |
| Local Institution | Portland | Oregon | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | Salt Lake City | Utah | — | — |
| Local Institution | Woodstock | Vermont | — | — |
| Local Institution | Charlottesville | Virginia | — | — |
| Local Institution | Bellevue | Washington | — | — |
| Local Institution | Seattle | Washington | — | — |
| Local Institution | Middleton | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00095823, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2026 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00095823 live on ClinicalTrials.gov.